Asia-Pacific Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Asia-Pacific bio-implants market is expected to reach USD 57,623.77 million by 2025, from USD 31,405.05 million in 2017 growing at a CAGR of 8.0% in the forecast period 2018 to 2025.
The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.
The key market players for Asia-Pacific Bio-Implants Market are listed below:
The Asia-Pacific bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, allograft segment is expected to dominate the Asia-pacific bio-implants market with 43.0% market share and are expected to reach USD 25,261.15 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, biomaterial metal is expected to dominate the Asia-pacific bio-implants market with 31.9% market share and is expected to reach USD 18,445.19 million by 2025, growing at a CAGR of 8.1% in the forecast period 2018 to 2025. However, alloy is expected to grow at the highest CAGR of 8.4% in the forecast period, to reach USD 15,727.91 million by 2025 from USD 8,287.20 million in 2017 in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical is expected to dominate the Asia-pacific bio-implants market with 60.7% market share and is expected to reach USD 34,271.71 million by 2025, growing at the highest CAGR of 7.7% in the forecast period 2018 to 2025. However, non-surgical is expected to grow at the highest CAGR of 8.5% in the forecast period, to reach USD 23,352.06 million by 2025 from USD 12,287.92 million in 2017 in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, hospitals is expected to dominate the Asia-pacific bio-implants market with 46.3% market share and is expected to reach USD 27,038.31 million by 2025, growing at the highest CAGR of 8.2% in the forecast period 2018 to 2025.
Based on geography, the Asia-Pacific bio-implants market is segmented into geographical regions, such as,
The report covers the present scenario and the growth prospects of the Asia-Pacific bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.
The key market players for Asia-Pacific Bio-Implants Market are listed below:
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- Bio-Rad Laboratories, Inc.
- Somnomed Limited
- Johnson & Johnson Services, Inc.
- Edwards Lifesciences Corporation
- F. Hoffmann-La Roche AG
- C.R. Bard, Inc.
- Mimedx Group, Inc.
- Biotronik Se & Co.Kg
- Product Type
- Type
- Material
- Mode of Administration
- End-user
The Asia-Pacific bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, allograft segment is expected to dominate the Asia-pacific bio-implants market with 43.0% market share and are expected to reach USD 25,261.15 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, biomaterial metal is expected to dominate the Asia-pacific bio-implants market with 31.9% market share and is expected to reach USD 18,445.19 million by 2025, growing at a CAGR of 8.1% in the forecast period 2018 to 2025. However, alloy is expected to grow at the highest CAGR of 8.4% in the forecast period, to reach USD 15,727.91 million by 2025 from USD 8,287.20 million in 2017 in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical is expected to dominate the Asia-pacific bio-implants market with 60.7% market share and is expected to reach USD 34,271.71 million by 2025, growing at the highest CAGR of 7.7% in the forecast period 2018 to 2025. However, non-surgical is expected to grow at the highest CAGR of 8.5% in the forecast period, to reach USD 23,352.06 million by 2025 from USD 12,287.92 million in 2017 in the forecast period 2018 to 2025.
The Asia-Pacific bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, hospitals is expected to dominate the Asia-pacific bio-implants market with 46.3% market share and is expected to reach USD 27,038.31 million by 2025, growing at the highest CAGR of 8.2% in the forecast period 2018 to 2025.
Based on geography, the Asia-Pacific bio-implants market is segmented into geographical regions, such as,
- China,
- Japan,
- India,
- South Korea,
- Australia,
- Thailand,
- Malaysia,
- Singapore,
- Indonesia,
- Philippines
- Rest of Asia-Pacific
The report covers the present scenario and the growth prospects of the Asia-Pacific bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. INTRODUCTION
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Asia-Pacific Bio-Implants Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. MARKET OVERVIEW
3.1. Drivers
3.1.1. Rising Number Of Aging And Geriatric Population
3.1.2. Changing Lifestyle Problems
3.1.3. Rising Incidence Of Chronic Diseases
3.1.4. Increasing Awareness About Cosmetic Implants
3.1.5. Technological Advancement In Implants
3.1.6. Rising Demand For Non-Surgical Bio-Implants
3.2. Restraints
3.2.1. High Cost Of Implants
3.2.2. Regulatory Scenario
3.2.3. Unfavourable Reimbursement Policies
3.3. Opportunities
3.3.1. Emerging Inclination For Mis Surgeries
3.3.2. Growing Number Of Diagnostic Centers And Clinics
3.3.3. Emerging Countries
3.3.4. Rising Medical Tourism
3.4. Challenges
3.4.1. Side-Effects Of Various Cosmetic Surgery
3.4.2. Lack Of Trained Professionals
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Orthopedics & Trauma
6.2.1. Reconstructive Joint Replacements
6.2.1.1. Knee Replacement Implants
6.2.1.2. Hip Replacement Implants
6.2.1.3. Extremities
6.2.2. Orthobiologics
6.2.2.1. Hyaluronic Acid
6.2.2.2. Bone Substitutes
6.2.2.3. Bone Growth Factors
6.2.2.4. Tissue Implants
6.2.2.5. Bone Cement
6.2.3. Trauma Implants
6.2.3.1. Internal Trauma Fixation Devices
6.2.3.2. Craniomaxillofacial Fixation Devices
6.2.3.3. Implantable Trauma Stimulators
6.2.4. Sports Medicine
6.3. Pacing Devices
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd)
6.3.2. Implantable Cardioverter Defibrillators (Icd)
6.3.3. Implantable Cardiac Pacemakers (Icp)
6.3.3.1. Single Chambered
6.3.3.2. Dual Chambered
6.3.3.3. Multiple Chambered
6.3.4. Pacing Accessories
6.3.4.1. Pacing Leads
6.3.4.2. Pacing Batteries
6.4. Stents & Related Implants
6.4.1. Coronary Stents
6.4.1.1. Drug-Eluting Stents
6.4.1.2. Bare-Metal Coronary Stents
6.4.1.3. Bioabsorbable Stents
6.4.2. Peripheral Stents
6.4.2.1. Endovascular Stent-Grafts
6.4.2.2. Renal & Related Stents
6.4.2.3. Femoral & Related Stents
6.4.2.4. Carotid Stents
6.4.3. Stent-Related Implants
6.4.3.1. Synthetic Grafts
6.4.3.2. Vascular Grafts
6.4.3.3. Peripheral Grafts
6.4.3.4. Vena Cava Filters
6.5. Spinal Implants
6.5.1. Thoracolumbar Implants
6.5.2. Intervertebral Spacers
6.5.3. Machined Allograft Spacers
6.5.4. Cervical Implants
6.5.5. Motion Preservation Implants
6.5.6. Implantable Spinal Stimulators
6.6. Ophthalmic Implants
6.6.1. Intraocular Lens
6.6.2. Glaucoma & Other Lenses
6.7. Structural Cardiac Implants
6.7.1. Heart Valves & Accessories
6.7.2. Tissue Heart Valves
6.7.3. Mechanical Heart Valves
6.7.4. Heart Valve Repair Devices
6.7.5. Ventricular Assist Device (Vad)
6.7.6. Implantable Heart Monitors
6.7.7. Insertable Loop Recorders (Ilrs)
6.7.8. Implantable Hemodynamic Monitors (Ihm)
6.8. Dental Implants
6.8.1. Plate Form Dental Implants
6.8.2. Root Form Dental Implants
6.9. Neurostimulators Implants
6.9.1. Cortical Stimulators
6.9.2. Deep Brain Stimulators
6.9.3. Sacral Nerve Stimulators
6.9.4. Spinal Cord Stimulators
6.9.5. Vagus Nerve Stimulators
6.10. Prosthetic Implants
6.10.1. Osseointegration
6.10.2. Titanium-Based Prosthetic Implants
6.11. Others
6.11.1. Gynecological Devices
6.11.2. Drug Implants
6.11.3. Cosmetic Implants
6.11.4. Gastroenterological Implants
6.11.5. Urological Implants
6.11.6. Skin & Wound Care
6.11.7. Otolaryngeal Implants
7. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY TYPE
7.1. Overview
7.2. Allograft
7.3. Autograft
7.4. Xenograft
7.5. Synthetic
7.6. Others
8. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY MATERIAL
8.1. Overview
8.2. Biomaterial Metal
8.2.1. Titanium
8.2.2. Gold
8.2.3. Silver
8.2.4. Platinum
8.3. Alloy
8.4. Polymer
8.4.1. Natural Polymers
8.4.2. Synthetic Polymers
8.5. Ceramics
8.6. Acrylic Hydrogel
9. ASIA-PACIFIC BIO-IMPLANTS MARKET, MODE OF ADMINISTRATION
9.1. Overview
9.2. Surgical
9.3. Non-Surgical
9.3.1. Injectable Fillers/Biomaterials
9.3.2. Osteogenic Injectable Bone Substitutes
9.3.3. Viscosupplementation
9.3.4. Viscoaugmentation
10. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY END-USER
10.1. Overview
10.2. Clinics
10.3. Hospitals
10.4. Ambulatory Surgical Centers
10.5. Others
11. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY GEOGRAPHY
11.1. Asia-Pacific
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. South Korea
11.1.5. Australia
11.1.6. Singapore
11.1.7. Thailand
11.1.8. Malaysia
11.1.9. Indonesia
11.1.10. Philippines
11.1.11. Rest Of Asia-Pacific
12. ASIA-PACIFIC BIO-IMPLANTS MARKET, COMPANY LANDSCAPE
12.1. Company Share Analysis: Asia Pacific
13. COMPANY PROFILES
13.1. Medtronic
13.1.1. Company Overview
13.1.2. Revenue Analysis
13.1.3. Product Portfolio
13.1.4. Recent Developments
13.2. Johnson & Johnson Services, Inc.
13.2.1. Company Overview
13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis
13.2.3. Product Portfolio
13.2.4. Recent Developments
13.3. Edward Lifesciences Corporation
13.3.1. Company Overview
13.3.2. Edward Lifesciences Corporation:Revenue Analysis
13.3.3. Product Portfolio
13.3.4. Recent Developments
13.4. Boston Scientific Corporation
13.4.1. Company Overview
13.4.2. Boston Scientific Corporation: Revenue Analysis
13.4.3. Product Portfolio
13.4.4. Recent Developments
13.5. Integra Lifesciences Corporation
13.5.1. Company Overview
13.5.2. Integra Lifesciences Corporation:Revenue Analysis
13.5.3. Product Portfolio
13.5.4. Recent Developments
13.6. Abbott
13.6.1. Company Overview
13.6.2. Abbott:Revenue Analysis
13.6.3. Product Portfolio
13.6.4. Recent Developments
13.7. C. R. Bard, Inc.
13.7.1. Company Overview
13.7.2. C. R. Bard, Inc.:Revenue Analysis
13.7.3. Product Portfolio
13.7.4. Recent Developments
13.8. Zimmer Biomet
13.8.1. Company Overview
13.8.2. Zimmer Biomet:Revenue Analysis
13.8.3. Product Portfolio
13.8.4. Recent Developments
13.9. Biotronik Se & Co. Kg
13.9.1. Company Overview
13.9.2. Biotronik Se & Co. Kg:Company Snapshot
13.9.3. Product Portfolio
13.9.4. Recent Developments
13.10. Lifenet Health, Inc.
13.10.1. Company Overview
13.10.2. Lifenet Health, Inc.:Company Snapshot
13.10.3. Product Portfolio
13.10.4. Recent Developments
13.11. Integrated Orbital Implants
13.11.1. Company Overview
13.11.2. Integrated Orbital Implants:Company Snapshot
13.11.3. Product Portfolio
13.11.4. Recent Developments
13.12. Smith & Nephew
13.12.1. Company Overview
13.12.2. Smith & Nephew:Revenue Analysis
13.12.3. Product Portfolio
13.12.4. Recent Developments
13.13. Stryker
13.13.1. Company Overview
13.13.2. Stryker:Revenue Analysis
13.13.3. Product Portfolio
13.13.4. Recent Developments
13.14. W. L. Gore & Associates, Inc
13.14.1. Company Overview
13.14.2. W. L. Gore & Associates, Inc:Company Snapshot
13.14.3. Product Portfolio
13.14.4. Recent Developments
13.15. Valeant Pharmaceuticals International Inc.
13.15.1. Company Overview
13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis
13.15.3. Product Portfolio
13.15.4. Recent Developments
13.16. Somnomed
13.16.1. Company Overview
13.16.2. Somnomed:Revenue Analysis
13.16.3. Product Portfolio
13.16.4. Recent Developments
13.17. Wright Medical Group N.V.
13.17.1. Company Overview
13.17.2. Wright Medical Group N.V.:Revenue Analysis
13.17.3. Product Portfolio
13.17.4. Recent Developments
13.18. Livanova Plc
13.18.1. Company Overview
13.18.2. Livanova Plc:Revenue Analysis
13.18.3. Product Portfolio
13.18.4. Recent Developments
13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott)
13.19.1. Company Overview
13.19.2. St. Jude Medical, Inc.:Company Snapshot
13.19.3. Product Portfolio
13.19.4. Recent Developments
13.20. Mimedx Group, Inc.
13.20.1. Company Overview
13.20.2. Mimedx Group, Inc.:Revenue Analysis
13.20.3. Product Portfolio
13.20.4. Recent Developments
13.21. Cook Group
13.21.1. Company Overview
13.21.2. Cook Group:Company Snapshot
13.21.3. Product Portfolio
13.21.4. Recent Developments
14. RELATED REPORTS
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Asia-Pacific Bio-Implants Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. MARKET OVERVIEW
3.1. Drivers
3.1.1. Rising Number Of Aging And Geriatric Population
3.1.2. Changing Lifestyle Problems
3.1.3. Rising Incidence Of Chronic Diseases
3.1.4. Increasing Awareness About Cosmetic Implants
3.1.5. Technological Advancement In Implants
3.1.6. Rising Demand For Non-Surgical Bio-Implants
3.2. Restraints
3.2.1. High Cost Of Implants
3.2.2. Regulatory Scenario
3.2.3. Unfavourable Reimbursement Policies
3.3. Opportunities
3.3.1. Emerging Inclination For Mis Surgeries
3.3.2. Growing Number Of Diagnostic Centers And Clinics
3.3.3. Emerging Countries
3.3.4. Rising Medical Tourism
3.4. Challenges
3.4.1. Side-Effects Of Various Cosmetic Surgery
3.4.2. Lack Of Trained Professionals
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Orthopedics & Trauma
6.2.1. Reconstructive Joint Replacements
6.2.1.1. Knee Replacement Implants
6.2.1.2. Hip Replacement Implants
6.2.1.3. Extremities
6.2.2. Orthobiologics
6.2.2.1. Hyaluronic Acid
6.2.2.2. Bone Substitutes
6.2.2.3. Bone Growth Factors
6.2.2.4. Tissue Implants
6.2.2.5. Bone Cement
6.2.3. Trauma Implants
6.2.3.1. Internal Trauma Fixation Devices
6.2.3.2. Craniomaxillofacial Fixation Devices
6.2.3.3. Implantable Trauma Stimulators
6.2.4. Sports Medicine
6.3. Pacing Devices
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd)
6.3.2. Implantable Cardioverter Defibrillators (Icd)
6.3.3. Implantable Cardiac Pacemakers (Icp)
6.3.3.1. Single Chambered
6.3.3.2. Dual Chambered
6.3.3.3. Multiple Chambered
6.3.4. Pacing Accessories
6.3.4.1. Pacing Leads
6.3.4.2. Pacing Batteries
6.4. Stents & Related Implants
6.4.1. Coronary Stents
6.4.1.1. Drug-Eluting Stents
6.4.1.2. Bare-Metal Coronary Stents
6.4.1.3. Bioabsorbable Stents
6.4.2. Peripheral Stents
6.4.2.1. Endovascular Stent-Grafts
6.4.2.2. Renal & Related Stents
6.4.2.3. Femoral & Related Stents
6.4.2.4. Carotid Stents
6.4.3. Stent-Related Implants
6.4.3.1. Synthetic Grafts
6.4.3.2. Vascular Grafts
6.4.3.3. Peripheral Grafts
6.4.3.4. Vena Cava Filters
6.5. Spinal Implants
6.5.1. Thoracolumbar Implants
6.5.2. Intervertebral Spacers
6.5.3. Machined Allograft Spacers
6.5.4. Cervical Implants
6.5.5. Motion Preservation Implants
6.5.6. Implantable Spinal Stimulators
6.6. Ophthalmic Implants
6.6.1. Intraocular Lens
6.6.2. Glaucoma & Other Lenses
6.7. Structural Cardiac Implants
6.7.1. Heart Valves & Accessories
6.7.2. Tissue Heart Valves
6.7.3. Mechanical Heart Valves
6.7.4. Heart Valve Repair Devices
6.7.5. Ventricular Assist Device (Vad)
6.7.6. Implantable Heart Monitors
6.7.7. Insertable Loop Recorders (Ilrs)
6.7.8. Implantable Hemodynamic Monitors (Ihm)
6.8. Dental Implants
6.8.1. Plate Form Dental Implants
6.8.2. Root Form Dental Implants
6.9. Neurostimulators Implants
6.9.1. Cortical Stimulators
6.9.2. Deep Brain Stimulators
6.9.3. Sacral Nerve Stimulators
6.9.4. Spinal Cord Stimulators
6.9.5. Vagus Nerve Stimulators
6.10. Prosthetic Implants
6.10.1. Osseointegration
6.10.2. Titanium-Based Prosthetic Implants
6.11. Others
6.11.1. Gynecological Devices
6.11.2. Drug Implants
6.11.3. Cosmetic Implants
6.11.4. Gastroenterological Implants
6.11.5. Urological Implants
6.11.6. Skin & Wound Care
6.11.7. Otolaryngeal Implants
7. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY TYPE
7.1. Overview
7.2. Allograft
7.3. Autograft
7.4. Xenograft
7.5. Synthetic
7.6. Others
8. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY MATERIAL
8.1. Overview
8.2. Biomaterial Metal
8.2.1. Titanium
8.2.2. Gold
8.2.3. Silver
8.2.4. Platinum
8.3. Alloy
8.4. Polymer
8.4.1. Natural Polymers
8.4.2. Synthetic Polymers
8.5. Ceramics
8.6. Acrylic Hydrogel
9. ASIA-PACIFIC BIO-IMPLANTS MARKET, MODE OF ADMINISTRATION
9.1. Overview
9.2. Surgical
9.3. Non-Surgical
9.3.1. Injectable Fillers/Biomaterials
9.3.2. Osteogenic Injectable Bone Substitutes
9.3.3. Viscosupplementation
9.3.4. Viscoaugmentation
10. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY END-USER
10.1. Overview
10.2. Clinics
10.3. Hospitals
10.4. Ambulatory Surgical Centers
10.5. Others
11. ASIA-PACIFIC BIO-IMPLANTS MARKET, BY GEOGRAPHY
11.1. Asia-Pacific
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. South Korea
11.1.5. Australia
11.1.6. Singapore
11.1.7. Thailand
11.1.8. Malaysia
11.1.9. Indonesia
11.1.10. Philippines
11.1.11. Rest Of Asia-Pacific
12. ASIA-PACIFIC BIO-IMPLANTS MARKET, COMPANY LANDSCAPE
12.1. Company Share Analysis: Asia Pacific
13. COMPANY PROFILES
13.1. Medtronic
13.1.1. Company Overview
13.1.2. Revenue Analysis
13.1.3. Product Portfolio
13.1.4. Recent Developments
13.2. Johnson & Johnson Services, Inc.
13.2.1. Company Overview
13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis
13.2.3. Product Portfolio
13.2.4. Recent Developments
13.3. Edward Lifesciences Corporation
13.3.1. Company Overview
13.3.2. Edward Lifesciences Corporation:Revenue Analysis
13.3.3. Product Portfolio
13.3.4. Recent Developments
13.4. Boston Scientific Corporation
13.4.1. Company Overview
13.4.2. Boston Scientific Corporation: Revenue Analysis
13.4.3. Product Portfolio
13.4.4. Recent Developments
13.5. Integra Lifesciences Corporation
13.5.1. Company Overview
13.5.2. Integra Lifesciences Corporation:Revenue Analysis
13.5.3. Product Portfolio
13.5.4. Recent Developments
13.6. Abbott
13.6.1. Company Overview
13.6.2. Abbott:Revenue Analysis
13.6.3. Product Portfolio
13.6.4. Recent Developments
13.7. C. R. Bard, Inc.
13.7.1. Company Overview
13.7.2. C. R. Bard, Inc.:Revenue Analysis
13.7.3. Product Portfolio
13.7.4. Recent Developments
13.8. Zimmer Biomet
13.8.1. Company Overview
13.8.2. Zimmer Biomet:Revenue Analysis
13.8.3. Product Portfolio
13.8.4. Recent Developments
13.9. Biotronik Se & Co. Kg
13.9.1. Company Overview
13.9.2. Biotronik Se & Co. Kg:Company Snapshot
13.9.3. Product Portfolio
13.9.4. Recent Developments
13.10. Lifenet Health, Inc.
13.10.1. Company Overview
13.10.2. Lifenet Health, Inc.:Company Snapshot
13.10.3. Product Portfolio
13.10.4. Recent Developments
13.11. Integrated Orbital Implants
13.11.1. Company Overview
13.11.2. Integrated Orbital Implants:Company Snapshot
13.11.3. Product Portfolio
13.11.4. Recent Developments
13.12. Smith & Nephew
13.12.1. Company Overview
13.12.2. Smith & Nephew:Revenue Analysis
13.12.3. Product Portfolio
13.12.4. Recent Developments
13.13. Stryker
13.13.1. Company Overview
13.13.2. Stryker:Revenue Analysis
13.13.3. Product Portfolio
13.13.4. Recent Developments
13.14. W. L. Gore & Associates, Inc
13.14.1. Company Overview
13.14.2. W. L. Gore & Associates, Inc:Company Snapshot
13.14.3. Product Portfolio
13.14.4. Recent Developments
13.15. Valeant Pharmaceuticals International Inc.
13.15.1. Company Overview
13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis
13.15.3. Product Portfolio
13.15.4. Recent Developments
13.16. Somnomed
13.16.1. Company Overview
13.16.2. Somnomed:Revenue Analysis
13.16.3. Product Portfolio
13.16.4. Recent Developments
13.17. Wright Medical Group N.V.
13.17.1. Company Overview
13.17.2. Wright Medical Group N.V.:Revenue Analysis
13.17.3. Product Portfolio
13.17.4. Recent Developments
13.18. Livanova Plc
13.18.1. Company Overview
13.18.2. Livanova Plc:Revenue Analysis
13.18.3. Product Portfolio
13.18.4. Recent Developments
13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott)
13.19.1. Company Overview
13.19.2. St. Jude Medical, Inc.:Company Snapshot
13.19.3. Product Portfolio
13.19.4. Recent Developments
13.20. Mimedx Group, Inc.
13.20.1. Company Overview
13.20.2. Mimedx Group, Inc.:Revenue Analysis
13.20.3. Product Portfolio
13.20.4. Recent Developments
13.21. Cook Group
13.21.1. Company Overview
13.21.2. Cook Group:Company Snapshot
13.21.3. Product Portfolio
13.21.4. Recent Developments
14. RELATED REPORTS
LIST OF FIGURES
Figure 1 Asia-Pacific Bio-Implants Market: Segmentation
Figure 2 Asia-Pacific Bio-Implants Market: Data Triangulation
Figure 3 Asia-Pacific Bio-Implants Market: Research Snapshot
Figure 4 Asia-Pacific Bio-Implants Market: Bottom Up Approach
Figure 5 Asia-Pacific Bio-Implants Market: Top Down Approach
Figure 6 Asia-Pacific Bio-Implants Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Asia-Pacific Bio-Implants Market
Figure 8 Number Of Cosmetic Surgeries Performed In 2000, 2015, And 2016 In U.S.
Figure 9 Asia-Pacific Bio-Implants Market: Segmentation
Figure 10 North America Is Expected To Dominate The Market For Bio-Implants And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025
Figure 11 Rising Number Of Aging And Geriatric Population, And Increased Incidences Of Chronic Diseases Are Expected To Drive The Market For Bio-Implants In The Forecast Period 2018 To 2025
Figure 12 Orthopedics & Trauma Segment Is Expected To Account For The Largest Share Of The Asia-Pacific Bio-Implants Market In 2018 & 2025
Figure 13 Asia-Pacific Bio-Implants Market: By Product Type, 2017
Figure 14 Asia-Pacific Bio-Implants Market: By Type, 2017
Figure 15 Asia-Pacific Bio-Implants Market: By Material, 2017
Figure 16 Asia-Pacific Bio-Implants Market: By Mode Of Administration, 2017
Figure 17 Asia-Pacific Bio-Implants Market: By End-User, 2017
Figure 18 Asia-Pacific Bio-Implants Market: Snapshot (2017)
Figure 19 Asia-Pacific Bio-Implants Market: By Country (2017)
Figure 20 Asia-Pacific Bio-Implants Market: By Country (2018 & 2025)
Figure 21 Asia-Pacific Bio-Implants Market, By Country (2017 & 2025)
Figure 22 Asia-Pacific Bio-Implants Market, By Product Type (2018 & 2025)
Figure 23 Asia Pacific Bio-Implants Market: Company Share 2017 (%)
Figure 1 Asia-Pacific Bio-Implants Market: Segmentation
Figure 2 Asia-Pacific Bio-Implants Market: Data Triangulation
Figure 3 Asia-Pacific Bio-Implants Market: Research Snapshot
Figure 4 Asia-Pacific Bio-Implants Market: Bottom Up Approach
Figure 5 Asia-Pacific Bio-Implants Market: Top Down Approach
Figure 6 Asia-Pacific Bio-Implants Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Asia-Pacific Bio-Implants Market
Figure 8 Number Of Cosmetic Surgeries Performed In 2000, 2015, And 2016 In U.S.
Figure 9 Asia-Pacific Bio-Implants Market: Segmentation
Figure 10 North America Is Expected To Dominate The Market For Bio-Implants And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025
Figure 11 Rising Number Of Aging And Geriatric Population, And Increased Incidences Of Chronic Diseases Are Expected To Drive The Market For Bio-Implants In The Forecast Period 2018 To 2025
Figure 12 Orthopedics & Trauma Segment Is Expected To Account For The Largest Share Of The Asia-Pacific Bio-Implants Market In 2018 & 2025
Figure 13 Asia-Pacific Bio-Implants Market: By Product Type, 2017
Figure 14 Asia-Pacific Bio-Implants Market: By Type, 2017
Figure 15 Asia-Pacific Bio-Implants Market: By Material, 2017
Figure 16 Asia-Pacific Bio-Implants Market: By Mode Of Administration, 2017
Figure 17 Asia-Pacific Bio-Implants Market: By End-User, 2017
Figure 18 Asia-Pacific Bio-Implants Market: Snapshot (2017)
Figure 19 Asia-Pacific Bio-Implants Market: By Country (2017)
Figure 20 Asia-Pacific Bio-Implants Market: By Country (2018 & 2025)
Figure 21 Asia-Pacific Bio-Implants Market, By Country (2017 & 2025)
Figure 22 Asia-Pacific Bio-Implants Market, By Product Type (2018 & 2025)
Figure 23 Asia Pacific Bio-Implants Market: Company Share 2017 (%)
